MYC and pancreatic ductal adenocarcinoma: It is also reported that LINC00346 can contribute to pancreatic ductal adenocarcinoma pathogenesis by activating c-Myc, while in gastric cancer, Myc could modulate LINC00346 to promote tumor progression.